Overview Divided Dose of TRAVATAN® Status: Completed Trial end date: 2011-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the incremental dosing of travoprost ophthalmic solution versus once a day dosing of TRAVATAN® in lowering intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). Phase: Phase 2 Details Lead Sponsor: Alcon ResearchTreatments: Ophthalmic SolutionsPharmaceutical SolutionsTravoprost